Epidermal growth factor receptor and proliferating cell nuclear antigen in astrocytomas.

Maiti, Arpan K; Ghosh, Keya; Chatterjee, Uttara; Chakrobarti, Sasanka; Chatterjee, Sandip; Basu, Samik.
Neurol India ; 2008 Oct-Dec; 56(4): 456-62
Artículo en Inglés | IMSEAR | ID: sea-121664

Documentos relacionados

  1. Epidermal growth factor receptor and proliferating cell nuclear antigen in astrocytomas.
  2. Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.
  3. Regulation of PCNA-protein interactions for genome stability.
  4. A FRET-Based Assay for the Identification of PCNA Inhibitors.
  5. A lesson for the maestro of the replication fork: Targeting the protein-binding interface of proliferating cell nuclear antigen for anticancer therapy.
  6. CDK-independent role of D-type cyclins in regulating DNA mismatch repair.
  7. Production of recombinant human proliferating cellular nuclear antigen (PCNA) for structural and biophysical characterization.
  8. Prognostic value of epidermal growth factor receptor amplification and EGFRvIII in glioblastoma: meta-analysis.
  9. CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization.
  10. Structural insights into the assembly and mechanism of mpox virus DNA polymerase complex F8-A22-E4-H5.